Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: Further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study
- 31 December 2005
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 150 (6), 1177-1184
- https://doi.org/10.1016/j.ahj.2005.01.044
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Effects of an early invasive strategy on ischemia and exercise tolerance among patients with unstable coronary artery diseaseAmerican Journal Of Medicine, 2003
- Early and Late Effects of Clopidogrel in Patients With Acute Coronary SyndromesCell Metabolism, 2003
- A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: Two-year follow-up of the FRISC-II invasive studyJournal of the American College of Cardiology, 2002
- Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trialThe Lancet, 2002
- Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment ElevationNew England Journal of Medicine, 2001
- Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE studyThe Lancet, 2001
- Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor TirofibanNew England Journal of Medicine, 2001
- Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trialThe Lancet, 2000
- Outcomes in Patients with Acute Non–Q-Wave Myocardial Infarction Randomly Assigned to an Invasive as Compared with a Conservative Management StrategyNew England Journal of Medicine, 1998
- One-year results of the thrombolysis in myocardial infarction (TIMI) IIIB clinical trial: A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave Myocardial infarctionJournal of the American College of Cardiology, 1995